Senate committee hears plan to create Centers for Medical Excellence funded by drug-rebate transfers

Senator Nicole Cannizzaro (Senate District 6, majority leader) told the Senate Finance Committee that Senate Bill 434 would create a statewide Health Care Access and Recruitment Grant Program, referred to in the bill as Centers for Medical Excellence (CME), to “provide financial incentives for health care access and health care workforce expansion.”

The bill as filed included a $50 million general‑fund appropriation. Cannizzaro said a conceptual amendment under consideration would remove that $50 million appropriation and, with interim finance committee approval, allow annual transfers of up to $25 million from the state’s prescription drug rebate program when surplus funds are available. “There’s a pathway to do that,” Cannizzaro said of recent legislation she expects will allow the state to collect surplus rebate monies.

The nut graf: the proposal is fiscal in this committee because the conceptual amendment changes the funding source and places parameters on transfers. Cannizzaro said the amendment includes guardrails: transfers would be requested by the Director of Health and Human Services, would be limited to $25 million per fiscal year, and section language would prohibit transfers if the account balance exceeds $60 million on July 1 of a fiscal year.

Committee members asked technical questions about the stability and predictability of rebate revenues. Senator Titus pressed the sponsor on how volatile rebate receipts are and whether the program would have fallback funding if rebate collections were insufficient. Cannizzaro replied that the bill does not force a transfer and that the director must request an appropriation with IFC oversight; she said the language was designed to avoid large unused balances accumulating in the account.

Supporters who testified included Charli de la Paz of the Nevada Nurses Association, who told the committee the bill is “a smart investment in Nevada’s health infrastructure,” and representatives from the University office of statewide initiatives and safety‑net clinics who said it would help address provider shortages. There was no opposition testimony recorded in the hearing.

The hearing closed without a committee action on the bill; the matter was presented for financial consideration and the sponsor agreed to the committee’s review of the conceptual amendment.

Ending: The committee heard details about funding constraints and oversight; the bill’s fiscal structure depends on whether the amendment is adopted and on future availability of surplus prescription drug rebate funds.